In human breast cancer, overexpression of GSK-3β is associated with poor prognosis indicators (increased tumor size, ER-negative disease, high pathological grade, PR-negative disease, and relapse after tumor resection) [80]. This evidence concerns the gene GSK3B and breast cancer.